Tarsus Pharmaceuticals (TARS) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026)
Tarsus Pharmaceuticals (TARS) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 58.66% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -10.19% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 2.65% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 24.11% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 12.18% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -95.71% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Tarsus Pharmaceuticals | 2.58 Bn | 2.48 Bn | 152.66 Mn | 534.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 534.09% |
| Dec 31, 2025 | 404.11% |
| Sep 30, 2025 | 140.12% |
| Jun 30, 2025 | 41.99% |
| Mar 31, 2025 | 108.30% |
| Dec 31, 2024 | 57.63% |
| Sep 30, 2024 | 48.27% |
| Jun 30, 2024 | 45.43% |
| Mar 31, 2024 | 12.15% |
| Dec 31, 2023 | 53.40% |
| Sep 30, 2023 | 69.72% |
| Jun 30, 2023 | 60.02% |
| Mar 31, 2023 | 30.38% |
| Dec 31, 2022 | 26.75% |
| Sep 30, 2022 | 83.24% |
| Jun 30, 2022 | 100.21% |
| Mar 31, 2022 | 55.35% |
| Dec 31, 2021 | 37.77% |
| Sep 30, 2021 | -14.07% |
| Dec 31, 2020 | 255.84% |